Thoratec Corporation 

(Public, NASDAQ:THOR)   Watch this stock   
Find more results for THOR
Nov 17, 2009
Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data - Webcast
Nov 10, 2009
CanaccordAdams Cardiovascular Conference
Nov 4, 2009
Q3 2009 Earnings Conference Call - Webcast
Nov 4, 2009
Q3 2009 Earnings Release
Sep 22, 2009
UBS Global Life Sciences Conference
Sep 9, 2009
Robert W. Baird & Co., Inc. Health Care Conference
More events from AOL Finance »    

Key stats and ratios

Q4 (Oct '09) 2009
Net profit margin 13.40% 7.19%
Operating margin 15.46% 8.21%
EBITD margin - 15.77%
Return on average assets 6.59% 3.47%
Return on average equity 9.49% 5.28%
Employees 1,110 -

Address

6035 Stoneridge Drive
Pleasanton, CA 94588
United States - Map
+1-925-8478600 (Phone)
+1-925-8478574 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Thoratec Corporation discussions

  View all discussions »

Description

Thoratec Corporation (Thoratec) is a manufacturer of mechanical circulatory support products for use by patients with heart failure (HF). The Company develops, manufactures and markets medical devices used for circulatory support. It also develops, manufactures and markets point-of-care diagnostic test systems and skin incision products. Thoratec operates in two operating divisions: Cardiovascular and International Technidyne Corporation (ITC), a wholly owned subsidiary. The Cardiovascular segment develops, manufactures and markets medical devices used for mechanical circulatory support (MCS). ITC designs, develops, manufactures and markets point-of-care diagnostic test systems and incision products. The Company conducts business both in the United States and internationally.

Officers and directors

Neil F. Dimick CPA
Chairman of the Board
Age: 60
Bio & Compensation - Reuters
Gerhard F. Burbach
President, Chief Executive Officer, Director
Age: 47
Bio & Compensation - Reuters
David V. Smith
Chief Financial Officer, Executive Vice President
Age: 49
Bio & Compensation - Reuters
Lawrence Cohen
President of ITC
Age: 59
Bio & Compensation - Reuters
David A. Lehman
Senior Vice President, General Counsel, Secretary
Age: 48
Bio & Compensation - Reuters
D. Keith Grossman
Director
Age: 49
Bio & Compensation - Reuters
J. Daniel Cole
Director
Age: 62
Bio & Compensation - Reuters
Daniel M. Mulvena
Director
Age: 60
Bio & Compensation - Reuters
Elisha W. Finney
Director
Age: 47
Bio & Compensation - Reuters
Steven H. Collis
Director
Age: 47
Bio & Compensation - Reuters